InMode Ltd. (INMD) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $13.21 (-2.26%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 11, 2026 | Jeff Johnson | Robert W. Baird | $17.00 | +28.7% |
| Apr 14, 2025 | Matthew Taylor | Jefferies | $15.00 | +13.6% |
| Oct 16, 2024 | Sam Elber | BTIG | $25.00 | +89.3% |
| Oct 12, 2024 | Matt Miksic | Barclays | $27.00 | +104.5% |
| Jul 23, 2024 | Matthew Taylor | Jefferies | $19.00 | +43.9% |
| Jul 12, 2024 | Caitlin Cronin | Canaccord Genuity | $16.00 | +21.2% |
| May 3, 2024 | Danielle Antalffy | UBS | $20.00 | +51.5% |
| Oct 13, 2023 | Caitlin Cronin | Canaccord Genuity | $22.00 | +66.6% |
| Feb 11, 2022 | Matthew Taylor | UBS | $90.00 | +581.6% |
Top Analysts Covering INMD
INMD vs Sector & Market
| Metric | INMD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.50 | 2.25 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +43.9% | +153002.0% | +21.5% |
| P/E Ratio | 9.71 | 3.46 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $368M | $370M | $372M | 4 |
| 2027-03-31 | $81M | $82M | $84M | 2 |
| 2027-06-30 | $95M | $96M | $97M | 2 |
| 2027-09-30 | $94M | $95M | $97M | 2 |
| 2027-12-31 | $108M | $109M | $111M | 2 |
| 2028-03-31 | $80M | $81M | $82M | 1 |
| 2028-06-30 | $96M | $97M | $99M | 1 |
| 2028-09-30 | $93M | $94M | $96M | 1 |
| 2028-12-31 | $114M | $115M | $117M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.44 | $1.44 | $1.45 | 4 |
| 2027-03-31 | $0.30 | $0.30 | $0.31 | 2 |
| 2027-06-30 | $0.37 | $0.38 | $0.39 | 2 |
| 2027-09-30 | $0.38 | $0.38 | $0.39 | 2 |
| 2027-12-31 | $0.44 | $0.45 | $0.46 | 2 |
| 2028-03-31 | $0.26 | $0.26 | $0.27 | 3 |
| 2028-06-30 | $0.33 | $0.34 | $0.35 | 3 |
| 2028-09-30 | $0.33 | $0.33 | $0.34 | 3 |
| 2028-12-31 | $0.44 | $0.44 | $0.45 | 3 |
Frequently Asked Questions
What is the analyst consensus for INMD?
The consensus among 2 analysts covering InMode Ltd. (INMD) is Buy with an average price target of $19.00.
What is the highest price target for INMD?
The highest price target for INMD is $90.00, set by Matthew Taylor at UBS on 2022-02-11.
What is the lowest price target for INMD?
The lowest price target for INMD is $15.00, set by Matthew Taylor at Jefferies on 2025-04-14.
How many analysts cover INMD?
2 analysts have issued ratings for InMode Ltd. in the past 12 months.
Is INMD a buy or sell right now?
Based on 2 analyst ratings, INMD has a consensus rating of Buy (2.50/5) with a +43.9% upside to the consensus target of $19.00.
What are the earnings estimates for INMD?
Analysts estimate INMD will report EPS of $1.44 for the period ending 2026-12-31, with revenue estimated at $370M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.